Skip to content

Telix Pharmaceuticals

Request correction

Telix is harnessing the power of targeted radiation to see and treat cancer.

Last updated September 1, 2026

AI crawler reads

4requests

1companies
  • Anthropic4
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Telix Pharmaceuticals is an Australian public company focused on developing targeted radiopharmaceuticals for cancer diagnosis and therapy. Its theranostic approach pairs imaging agents with therapeutics to improve patient outcomes. The company has commercial products Illuccix and Gozellix for prostate cancer imaging and is advancing a pipeline across urologic oncology, neurologic oncology, and other solid tumors.

History

Telix Pharmaceuticals is an Australian public company. It is harnessing the power of targeted radiation to see and treat cancer, with a theranostic approach that pairs radiopharmaceutical imaging agents and therapeutics. The company has commercial products Illuccix and Gozellix for prostate cancer imaging, and is advancing a pipeline across urologic oncology, neurologic oncology, and other solid tumors.

Products and positioning

  • Illuccix®

    Approved in United States, Canada, Australia, United Kingdom, Brazil and countries in the European Union for prostate cancer imaging.

  • Gozellix®

    Approved by the United States Food and Drug Administration (FDA) for prostate cancer imaging.

Recent events

  • Unconfirmed

    China Grand Pharma signs commercial partnership with Telix[6]

    China Grand Pharmaceutical and Healthcare Holdings Limited signed a A$400 million licence and strategic commercial partnership with Telix Pharmaceuticals. The agreement grants China Grand Pharma exclusive development and commercialisation rights to Telix's specified diagnostic and therapeutic products in Greater China.

  • Reported

    Telix announces agreement to acquire TheraPharm[7]

    Telix Pharmaceuticals announced that it had entered into an agreement with Scintec Diagnostics to acquire TheraPharm GmbH, a Swiss-German biotechnology company.

Read more

Sources8 sources

Cite this profile: Cite the canonical profile. /brand-wiki/telix-pharmaceuticals-limited · Editorial policy · How profiles are compiled